Hollow porous silica nanoparticles for targeted drug delivery
Hollow porous silica nanoparticles for targeted drug delivery
批准号:
7359747
负责人:
David Oupicky
金额:
$18.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2009-07-31
关键词:
Animal ModelAntineoplastic AgentsAreaBehaviorBiologicalCaliberCancer ModelCellsChemistryClassClinicalCompatibleCultured CellsDataDevelopmentDrug ControlsDrug Delivery SystemsDrug FormulationsExhibitsFunding MechanismsGenesGoalsHeat-Shock Proteins 90HybridsImageIn VitroKineticsLigandsMalignant NeoplasmsMalignant neoplasm of prostateMediatingModelingMusNanotechnologyNatureNumbersPathway interactionsPeptidesPermeabilityPharmaceutical PreparationsPliabilityPolymer ChemistryPolymersPreparationProstateProstatic NeoplasmsRangeResearchShapesSilicon DioxideStagingStimulusStructureSurfaceSurface PropertiesSystemTestingTumor BiologyUrinationXenograft procedureantitumor agentbasebiomaterial compatibilitycancer cellcancer therapyclinically relevantcopolymerdesignimprovedin vivoinhibitor/antagonistnanomaterialsnanoparticleneoplastic cellnovelparticleresponsesizesmall moleculetargeted deliverytumoruptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Mesoporous silica-based materials show number of attractive features for biomedical applications, such as stable mesoporous structures, large surface areas, tunable pore sizes and volumes, good biocompatibility, and well-defined surface properties available for further functionalization. The objective of this project is to develop polymer-modified hollow porous silica nanoparticles with a reversible control of drug release that will be suitable for target-specific drug delivery. To examine the clinical potential of these novel nanoparticle-mediated delivery systems, we choose clinically relevant anti-tumor agent and prostate tumor model. We will accomplish the overall objectives of this application by pursuing the following specific aims: 1. Prepare hollow porous silica (HPS) nanoparticles with reversible pH-controlled drug release. 2. Evaluate anti-proliferative effect of the HPS nanoparticles loaded with 17-AAG, an inhibitor of heat shock protein 90 (Hsp90), in vitro and tumor inhibition in a prostate cancer model in vivo. We anticipate that the novel HPS nanoparticles developed in this proposal will establish a new drug delivery platform suitable for a variety of biomedical applications. The design flexibility of these hybrid inorganic/organic nanoparticles is particularly suitable for the preparation of systems that will combine multiple functions within a single formulation, in particular imaging and drug delivery. Early application to a clinically relevant problem will allow fast progression of this nanotechnology platform to application in cancer treatment. The exploratory nature of this proposal should be ideally suited for the R21 funding mechanism.
Project Narrative: This project deals with the design of smart porous nanoparticles for targeted delivery of drugs into prostate tumors. The proposed nanoparticles are designed to open their pores selectively inside of tumor cells and should find application in the treatment of a wide range of cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
-
批准号:10356892
-
项目类别:
-
资助金额:$51.74万
-
财政年份:2020
-
负责人:David Oupicky
-
依托单位:
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
-
批准号:10652269
-
项目类别:
-
资助金额:$51.74万
-
财政年份:2020
-
负责人:David Oupicky
-
依托单位:
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
-
批准号:10207371
-
项目类别:
-
资助金额:$38.9万
-
财政年份:2019
-
负责人:David Oupicky
-
依托单位:
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
-
批准号:9758400
-
项目类别:
-
资助金额:$38.9万
-
财政年份:2019
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine- Pilot Projects
-
批准号:10163874
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Development of siRNA conjugates for combination treatment of acute kidney injury
-
批准号:9789273
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine- Nanomaterial Characterization Core
-
批准号:10163872
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Development of siRNA conjugates for combination treatment of acute kidney injury
-
批准号:10213017
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Development of siRNA conjugates for combination treatment of acute kidney injury
-
批准号:10434824
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Development of siRNA conjugates for combination treatment of acute kidney injury
-
批准号:9976515
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine
-
批准号:10163870
-
项目类别:
-
资助金额:$114.38万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine- Administrative Core
-
批准号:10163871
-
项目类别:
-
资助金额:$44.23万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine
-
批准号:10441205
-
项目类别:
-
资助金额:$114.38万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nanoparticles based on histone deacetylase inhibitors for combination treatments
-
批准号:9043064
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2015
-
负责人:David Oupicky
-
依托单位:
Dual-function nanoparticles for oral treatment of inflammatory bowel disease
-
批准号:9047281
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2015
-
负责人:David Oupicky
-
依托单位:
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio
-
批准号:8701615
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2014
-
负责人:David Oupicky
-
依托单位:
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio
-
批准号:8891423
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2014
-
负责人:David Oupicky
-
依托单位:
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio
-
批准号:9314566
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2014
-
负责人:David Oupicky
-
依托单位:
Drug-based polycations for combination drug-gene delivery
-
批准号:8614186
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2013
-
负责人:David Oupicky
-
依托单位:
Drug-based polycations for combination drug-gene delivery
-
批准号:8302774
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2012
-
负责人:David Oupicky
-
依托单位:
海外基金